SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-254458
Filing Date
2017-08-10
Accepted
2017-08-10 16:11:55
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d431843d10q.htm 10-Q 627171
2 EX-10.3 d431843dex103.htm EX-10.3 50069
3 EX-31.1 d431843dex311.htm EX-31.1 6632
4 EX-31.2 d431843dex312.htm EX-31.2 6425
5 EX-32.1 d431843dex321.htm EX-32.1 4464
12 GRAPHIC g431843snap2.jpg GRAPHIC 83455
  Complete submission text file 0001193125-17-254458.txt   2607751

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT drna-20170630.xml EX-101.INS 375305
7 XBRL TAXONOMY EXTENSION SCHEMA drna-20170630.xsd EX-101.SCH 30336
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20170630_cal.xml EX-101.CAL 44743
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20170630_def.xml EX-101.DEF 70524
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20170630_lab.xml EX-101.LAB 224846
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20170630_pre.xml EX-101.PRE 149181
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 171021592
SIC: 2834 Pharmaceutical Preparations